This Stock Is Quietly Becoming a Cornerstone of the Artificial Intelligence Boom
Micron Technology's advanced memory chips are proving essential in the AI race.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
GSR Launches Crypto Core3 ETF (BESO)
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Micron Technology's advanced memory chips are proving essential in the AI race.
The SEC has agreed to dismiss its enforcement case against Gemini after investors in its defunct lending program recovered their crypto assets in full. The...
"Both of us were widowed. We are in our late 60s and retired."
Friday was a quiet day in markets for the most part, but there was one big move that raised eyebrows: Late in the New York morning, the U.S. dollar suddenl...
U.S. airlines have already canceled nearly 6,000 flights through Sunday ahead of a winter storm expected to wallop two-thirds of the United States over the...
On Wednesday, Nvidia Corp (NASDAQ:NVDA) CEO Jensen Huang revealed that selling shares after the company's 1999 IPO to buy his parents a Mercedes is his "on...
UBS maintains neutral view on UK equities, favors earnings over valuations
Shortfall in data-center chip supply weighs on turnaround hopes.
The company is also currently facing a 30-day suspension of its manufacturing and dealer licenses in California for deceptive marketing about Autopilot's c...
Nvidia Shares Rise After Report China Allows Tech Giants to Prep AI Chip Purchases
Futures fell after as Intel dived, but Nvidia H200 chip sales may be close in China. Tesla has big self-driving robotaxi news..
Bausch Health stock plunges after hepatic encephalopathy trials fail